Single peptide Vial strength 0.15 mg / 75 IU
HMG0.15 mg / 75 IU
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
HMG, explained simply
Human menopausal gonadotropin is a preparation with FSH and LH activity used in clinical reproductive care.
Research area
Sperm production and hypogonadotropic hypogonadism
How it works
FSH activity supports germ-cell maturation, while LH activity contributes to gonadal stimulation.
Why it matters
It highlights the separate roles of FSH and LH and why LH-like stimulation alone may not provide both signals.
What has been observed
Clinical studies of hMG with hCG are reported in men with specific causes of infertility.
Effects and points to consider
Reproductive response depends on diagnosis and specialist monitoring. Reported schedules do not replace prescribed treatment.
01 / Vial strength 0.15 mg / 75 IU
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 75 IU / 0.15 mg HMG |
|---|---|
| Final volume | 1 mL |
| Concentration | 75 IU/mL |
Male Fertility Protocol (1 mL = 75 IU/mL)
| Week/Phase | Dose per Injection | Volume per Injection |
|---|---|---|
| Weeks 1–12 | 75 IU (0.15 mg) | 1.0 mL |
| Weeks 13–16 (optional extension) | 75 IU (0.15 mg) | 1.0 mL |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.